{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:57:33Z","timestamp":1793321853025,"version":"4.5.0"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"DOI":"10.1038\/s41569-026-01334-3","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:01:17Z","timestamp":1790510477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1428-879X","authenticated-orcid":false,"given":"Behnood","family":"Bikdeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0146-5611","authenticated-orcid":false,"given":"Sina","family":"Rashedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Pfeferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3189-242X","authenticated-orcid":false,"given":"Christopher","family":"Amalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darsiya","family":"Krishnathasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0244-3716","authenticated-orcid":false,"given":"Syed","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton H.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Sawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-7721","authenticated-orcid":false,"given":"David","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-0767","authenticated-orcid":false,"given":"Manuel","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-0513","authenticated-orcid":false,"given":"Parham","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"Laurent","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Jacques","family":"Noubiap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-9824","authenticated-orcid":false,"given":"Lisa K.","family":"Moores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Kindzelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0387-5326","authenticated-orcid":false,"given":"George A.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-6143","authenticated-orcid":false,"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-127X","authenticated-orcid":false,"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"1334_CR1","doi-asserted-by":"publisher","first-page":"e2240373","DOI":"10.1001\/jamanetworkopen.2022.40373","volume":"5","author":"E Neeman","year":"2022","unstructured":"Neeman, E. et al. Trends and risk factors for venous thromboembolism among hospitalized medical patients. JAMA Netw. Open. 5, e2240373 (2022).","journal-title":"JAMA Netw. Open."},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe, A. M. & Raskob, G. E. Global burden Of thrombosis: epidemiologic aspects. Circulation Res. 118, 1340\u20131347 (2016).","journal-title":"Circulation Res."},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","volume":"150","author":"KE Joynt Maddox","year":"2024","unstructured":"Joynt Maddox, K. E. et al. Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-Prevalence of Risk Factors and Disease: a presidential advisory from the American Heart Association. Circulation 150, e65\u2013e88 (2024).","journal-title":"Circulation"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jacc.2010.05.071","volume":"57","author":"CV Pollack","year":"2011","unstructured":"Pollack, C. V. et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J. Am. Coll. Cardiol. 57, 700\u2013706 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJMoa012835","volume":"346","author":"TJ Nuckton","year":"2002","unstructured":"Nuckton, T. J. et al. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N. Engl. J. Med. 346, 1281\u20131286 (2002).","journal-title":"N. Engl. J. Med."},{"key":"1334_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos, L. D. J. & Ware, L. B. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet 400, 1145\u20131156 (2022).","journal-title":"Lancet"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.blre.2014.07.003","volume":"28","author":"FA Klok","year":"2014","unstructured":"Klok, F. A. et al. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 28, 221\u2013226 (2014).","journal-title":"Blood Rev."},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1093\/eurheartj\/ehac206","volume":"43","author":"L Valerio","year":"2022","unstructured":"Valerio, L. et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur. Heart J. 43, 3387\u20133398 (2022).","journal-title":"Eur. Heart J."},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMra0910203","volume":"364","author":"G Piazza","year":"2011","unstructured":"Piazza, G. & Goldhaber, S. Z. Chronic thromboembolic pulmonary hypertension. N. Engl. J. Med. 364, 351\u2013360 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/eurheartj\/ehad314","volume":"44","author":"IM Lang","year":"2023","unstructured":"Lang, I. M. & Delcroix, M. Novel acquisitions in chronic thromboembolic pulmonary hypertension. Eur. Heart J. 44, 2417\u20132419 (2023).","journal-title":"Eur. Heart J."},{"key":"1334_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","volume":"2016","author":"SR Kahn","year":"2016","unstructured":"Kahn, S. R. The post-thrombotic syndrome. Hematol. Am. Soc. Hematol Educ. Program. 2016, 413\u2013418 (2016).","journal-title":"Hematol. Am. Soc. Hematol Educ. Program."},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jtha.2025.12.017","volume":"24","author":"L Valerio","year":"2026","unstructured":"Valerio, L. et al. Post-thrombotic syndrome: risk after deep vein thrombosis and estimates of its incidence and prevalence in Europe. J. Thromb. Haemost. 24, 1690\u20131699 (2026).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood.2019002364","volume":"135","author":"C Kearon","year":"2020","unstructured":"Kearon, C. & Kahn, S. R. Long-term treatment of venous thromboembolism. Blood 135, 317\u2013325 (2020).","journal-title":"Blood"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1056\/NEJMoa2509426","volume":"393","author":"G Piazza","year":"2025","unstructured":"Piazza, G. et al. Apixaban for extended treatment of provoked venous thromboembolism. N. Engl. J. Med. 393, 1166\u20131176 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1182\/hematology.2020002268","volume":"2020","author":"FN Ainle","year":"2020","unstructured":"Ainle, F. N. & Kevane, B. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)? Hematol. Am. Soc. Hematol Educ. Program. 2020, 201\u2013212 (2020).","journal-title":"Hematol. Am. Soc. Hematol Educ. Program."},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1055\/a-1646-2244","volume":"122","author":"B Bikdeli","year":"2022","unstructured":"Bikdeli, B. et al. Extended-duration low-intensity apixaban to prevent recurrence in patients with provoked venous thromboembolism and enduring risk factors: rationale and design of the HI-PRO trial. Thromb. Haemost. 122, 1061\u20131070 (2022).","journal-title":"Thromb. Haemost."},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","volume":"7","author":"S Middeldorp","year":"2023","unstructured":"Middeldorp, S. et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. 7, 7101\u20137138 (2023).","journal-title":"Blood Adv."},{"key":"1334_CR18","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis, J. D. et al. Perioperative management of antithrombotic therapy: an American college of chest physicians clinical practice guideline. Chest 162, e207\u2013e243 (2022).","journal-title":"Chest"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/jth.14598","volume":"17","author":"AC Spyropoulos","year":"2019","unstructured":"Spyropoulos, A. C. et al. Scientific and Standardization Committee Communication: guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural\/surgical bleed risk and patient-specific thromboembolic risk. J. Thromb. Haemost. 17, 1966\u20131972 (2019).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103447","volume":"22","author":"D Menichelli","year":"2023","unstructured":"Menichelli, D. et al. Risk of venous thromboembolism in autoimmune diseases: a comprehensive review. Autoimmun. Rev. 22, 103447 (2023).","journal-title":"Autoimmun. Rev."},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"1901647","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"SV Konstantinides","year":"2019","unstructured":"Konstantinides, S. V. et al. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur. Respir. J. 54, 1901647 (2019).","journal-title":"Eur. Respir. J."},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1161\/CIRCULATIONAHA.111.084467","volume":"125","author":"MA Rogers","year":"2012","unstructured":"Rogers, M. A. et al. Triggers of hospitalization for venous thromboembolism. Circulation 125, 2092\u20132099 (2012).","journal-title":"Circulation"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","volume":"107","author":"FA Anderson Jr.","year":"2003","unstructured":"Anderson, F. A. Jr. & Spencer, F. A. Risk factors for venous thromboembolism. Circulation 107, I9\u201316 (2003).","journal-title":"Circulation"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.111.025627","volume":"124","author":"HT Sorensen","year":"2011","unstructured":"Sorensen, H. T. et al. Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation 124, 1435\u20131441 (2011).","journal-title":"Circulation"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejim.2009.06.001","volume":"20","author":"P Prandoni","year":"2009","unstructured":"Prandoni, P. et al. Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. Eur. J. Intern. Med. 20, 470\u2013473 (2009).","journal-title":"Eur. J. Intern. Med."},{"key":"1334_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tru.2023.100151","volume":"13","author":"RE Clapham","year":"2023","unstructured":"Clapham, R. E., Marrinan, E. & Roberts, L. N. VTE prevention in medical inpatients \u2014 current approach and controversies. Thrombosis Update 13, 100151 (2023).","journal-title":"Thrombosis Update"},{"key":"1334_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/s-0039-1697664","volume":"120","author":"SY Lin","year":"2020","unstructured":"Lin, S. Y., Chang, Y. L., Yeh, H. C., Lin, C. L. & Kao, C. H. Blood transfusion and risk of venous thromboembolism: a population-based cohort study. Thromb. Haemost. 120, 156\u2013167 (2020).","journal-title":"Thromb. Haemost."},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin, B. A., Ayoob, R. & Smoyer, W. E. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin. J. Am. Soc. Nephrol. 7, 513\u2013520 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2025.15222","volume":"334","author":"G Piazza","year":"2025","unstructured":"Piazza, G. et al. Superficial vein thrombosis: a review. JAMA 334, 2020\u20132030 (2025).","journal-title":"JAMA"},{"key":"1334_CR30","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1111\/jth.14865","volume":"18","author":"M W\u00fcrtz","year":"2020","unstructured":"W\u00fcrtz, M. et al. Comorbidity and risk of venous thromboembolism after hospitalization for first-time myocardial infarction: a population-based cohort study. J. Thromb. Haemost. 18, 1974\u20131985 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/SLA.0b013e31815792d8","volume":"246","author":"NT Nguyen","year":"2007","unstructured":"Nguyen, N. T. et al. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Ann. Surg. 246, 1021\u20131027 (2007).","journal-title":"Ann. Surg."},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2147\/CLEP.S172306","volume":"10","author":"E Horv\u00e1th-Puh\u00f3","year":"2018","unstructured":"Horv\u00e1th-Puh\u00f3, E. et al. Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clin. Epidemiol. 10, 1371\u20131380 (2018).","journal-title":"Clin. Epidemiol."},{"key":"1334_CR33","first-page":"131","volume":"2","author":"B Linnemann","year":"2014","unstructured":"Linnemann, B. et al. Prevalence of established risk factors for venous thromboembolism according to age. J. Vasc. Surgery: Venous Lymphatic Disord. 2, 131\u2013139 (2014).","journal-title":"J. Vasc. Surgery: Venous Lymphatic Disord."},{"key":"1334_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","volume":"16","author":"JJ Lee","year":"2014","unstructured":"Lee, J. J. & Pope, J. E. A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases. Arthritis Res. Ther. 16, 435 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"1334_CR35","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","volume":"101","author":"M Galli","year":"2003","unstructured":"Galli, M., Luciani, D., Bertolini, G. & Barbui, T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101, 1827\u20131832 (2003).","journal-title":"Blood"},{"key":"1334_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-026-01269-9","author":"S Rashedi","year":"2026","unstructured":"Rashedi, S. et al. Antiphospholipid antibodies and cardiovascular thrombosis. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-026-01269-9 (2026).","journal-title":"Nat. Rev. Cardiol."},{"key":"1334_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.thromres.2022.01.007","volume":"211","author":"B Bikdeli","year":"2022","unstructured":"Bikdeli, B. et al. Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism. Thromb. Res. 211, 10\u201318 (2022).","journal-title":"Thromb. Res."},{"key":"1334_CR38","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/bloodadvances.2023012200","volume":"8","author":"BD Lam","year":"2024","unstructured":"Lam, B. D. et al. Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis. Blood Adv. 8, 2991\u20133000 (2024).","journal-title":"Blood Adv."},{"key":"1334_CR39","doi-asserted-by":"publisher","unstructured":"Rashedi, S. et al. Optimizing the accuracy of natural language processing tools for pulmonary embolism detection through integration with claims data: the PE-EHR+ study. Circulation\u00a0https:\/\/doi.org\/10.1161\/circ.152.suppl_3.4367840\u00a0(2026).","DOI":"10.1161\/circ.152.suppl_3.4367840"},{"key":"1334_CR40","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jacr.2021.01.014","volume":"18","author":"B Wildman-Tobriner","year":"2021","unstructured":"Wildman-Tobriner, B. et al. Missed incidental pulmonary embolism: harnessing artificial intelligence to assess prevalence and improve quality improvement opportunities. J. Am. Coll. Radiol. 18, 992\u2013999 (2021).","journal-title":"J. Am. Coll. Radiol."},{"key":"1334_CR41","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230702","volume":"309","author":"SA Rothenberg","year":"2023","unstructured":"Rothenberg, S. A. et al. Prospective evaluation of AI triage of pulmonary emboli on CT pulmonary angiograms. Radiology 309, e230702 (2023).","journal-title":"Radiology"},{"key":"1334_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110402","volume":"193","author":"E Lanza","year":"2025","unstructured":"Lanza, E., Ammirabile, A. & Francone, M. Meta-analysis of AI-based pulmonary embolism detection: how reliable are deep learning models? Comput. Biol. Med. 193, 110402 (2025).","journal-title":"Comput. Biol. Med."},{"key":"1334_CR43","doi-asserted-by":"publisher","first-page":"e234059","DOI":"10.1001\/jamanetworkopen.2023.4059","volume":"6","author":"GS Iyer","year":"2023","unstructured":"Iyer, G. S., Tesfaye, H., Khan, N. F., Zakoul, H. & Bykov, K. Trends in the use of oral anticoagulants for adults with venous thromboembolism in the US, 2010-2020. JAMA Netw. Open. 6, e234059 (2023).","journal-title":"JAMA Netw. Open."},{"key":"1334_CR44","doi-asserted-by":"publisher","first-page":"1700275","DOI":"10.1183\/13993003.00275-2017","volume":"49","author":"FA Klok","year":"2017","unstructured":"Klok, F. A. & Huisman, M. V. Management of incidental pulmonary embolism. Eur. Respir. J. 49, 1700275 (2017).","journal-title":"Eur. Respir. J."},{"key":"1334_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102424","volume":"8","author":"CD Khairani","year":"2024","unstructured":"Khairani, C. D. et al. Direct oral anticoagulants for treatment of venous thrombosis: illustrated review of appropriate use. Res. Pract. Thromb. Haemost. 8, 102424 (2024).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1334_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2023.10.026","volume":"83","author":"T Kobayashi","year":"2024","unstructured":"Kobayashi, T. et al. Contemporary management and outcomes of patients with high-risk pulmonary embolism. J. Am. Coll. Cardiol. 83, 35\u201343 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR47","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jacc.2025.07.061","volume":"86","author":"S Rashedi","year":"2025","unstructured":"Rashedi, S. et al. Fibrinolytic therapy for thromboembolic diseases: approved indications and future directions. J. Am. Coll. Cardiol. 86, 1065\u20131087 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR48","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0044-1781451","volume":"50","author":"S Rashedi","year":"2024","unstructured":"Rashedi, S. et al. Fibrinolytic agents in thromboembolic diseases: historical perspectives and approved indications. Semin. Thromb. Hemost. 50, 773\u2013789 (2024).","journal-title":"Semin. Thromb. Hemost."},{"key":"1334_CR49","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1161\/CIR.0000000000001117","volume":"147","author":"JB Goldberg","year":"2023","unstructured":"Goldberg, J. B. et al. Surgical management and mechanical circulatory support in high-risk pulmonary embolisms: historical context, current status, and future directions: a scientific statement from the American heart association. Circulation 147, e628\u2013e647 (2023).","journal-title":"Circulation"},{"key":"1334_CR50","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah, G. A., Fuster, V., Murray, C. J. L., Roth, G. A. & Global Burden of Cardiovascular Diseases and Risks Collaborators. Global burden of cardiovascular diseases and risks, 1990\u20132022. J. Am. Coll. Cardiol. 82, 2350\u20132473 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR51","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","volume":"86","author":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators","year":"2025","unstructured":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990\u20132023. J. Am. Coll. Cardiol. 86, 2167\u20132243 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR52","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","volume":"34","author":"GE Raskob","year":"2014","unstructured":"Raskob, G. E. et al. Thrombosis: a major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol. 34, 2363\u20132371 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1334_CR53","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2025.08.078","volume":"86","author":"B Bikdeli","year":"2025","unstructured":"Bikdeli, B. et al. Venous thromboembolism: global burden of disease estimates are missing a common cardiovascular condition. J. Am. Coll. Cardiol. 86, 2135\u20132138 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR54","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jacc.2025.12.027","volume":"87","author":"RK Wadhera","year":"2026","unstructured":"Wadhera, R. K. et al. Cardiovascular statistics in the United States, 2026: JACC stats. J. Am. Coll. Cardiol. 87, 1094\u20131134 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.thromres.2016.06.033","volume":"145","author":"MK Puurunen","year":"2016","unstructured":"Puurunen, M. K. et al. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb. Res. 145, 27\u201333 (2016).","journal-title":"Thromb. Res."},{"key":"1334_CR56","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1055\/s-0040-1722189","volume":"121","author":"AM Wendelboe","year":"2021","unstructured":"Wendelboe, A. M. et al. Incidence of\u00a0venous thromboembolism in a racially diverse population of Oklahoma County, Oklahoma. Thromb. Haemost. 121, 816\u2013825 (2021).","journal-title":"Thromb. Haemost."},{"key":"1334_CR57","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jvsv.2017.04.006","volume":"5","author":"A Brahmandam","year":"2017","unstructured":"Brahmandam, A., Abougergi, M. S. & Ochoa Chaar, C. I. National trends in hospitalizations for venous thromboembolism. J. Vasc. Surg. Venous Lymphat. Disord. 5, 621\u2013629.e2 (2017).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"1334_CR58","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.chest.2019.05.021","volume":"156","author":"E Pauley","year":"2019","unstructured":"Pauley, E., Orgel, R., Rossi, J. S. & Strassle, P. D. Age-stratified national trends in pulmonary embolism admissions. Chest 156, 733\u2013742 (2019).","journal-title":"Chest"},{"key":"1334_CR59","doi-asserted-by":"publisher","first-page":"6610196","DOI":"10.1155\/emmi\/6610196","volume":"2025","author":"A Aalam","year":"2025","unstructured":"Aalam, A., Bokhary, D., Alsabban, A. & Bakhribah, A. National trends in pulmonary embolism visit in United States emergency departments and associated costs (2006\u20132018). Emerg. Med. Int. 2025, 6610196 (2025).","journal-title":"Emerg. Med. Int."},{"key":"1334_CR60","first-page":"e41","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin, S. S. et al. Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 151, e41\u2013e660 (2025).","journal-title":"Circulation"},{"key":"1334_CR61","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1358863X15573839","volume":"20","author":"GS Alotaibi","year":"2015","unstructured":"Alotaibi, G. S., Wu, C., Senthilselvan, A. & McMurtry, M. S. The validity of ICD codes coupled with imaging procedure codes for identifying acute venous thromboembolism using administrative data. Vasc. Med. 20, 364\u2013368 (2015).","journal-title":"Vasc. Med."},{"key":"1334_CR62","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11239-019-01966-y","volume":"48","author":"P W\u00e4ndell","year":"2019","unstructured":"W\u00e4ndell, P. et al. Venous thromboembolism 2011\u20132018 in Stockholm: a demographic study. J. Thromb. Thrombolysis 48, 668\u2013673 (2019).","journal-title":"J. Thromb. Thrombolysis"},{"key":"1334_CR63","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/a-2402-6192","volume":"125","author":"K Glise Sandblad","year":"2025","unstructured":"Glise Sandblad, K. et al. Time trends and excess mortality compared to population controls after a first-time pulmonary embolism or deep vein thrombosis. Thromb. Haemost. 125, 364\u2013375 (2025).","journal-title":"Thromb. Haemost."},{"key":"1334_CR64","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1160\/TH16-03-0205","volume":"116","author":"A Delluc","year":"2016","unstructured":"Delluc, A. et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb. Haemost. 116, 967\u2013974 (2016).","journal-title":"Thromb. Haemost."},{"key":"1334_CR65","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1160\/TH17-08-0531","volume":"118","author":"P Lehnert","year":"2018","unstructured":"Lehnert, P., Lange, T., M\u00f8ller, C. H., Olsen, P. S. & Carlsen, J. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb. Haemost. 118, 539\u2013546 (2018).","journal-title":"Thromb. Haemost."},{"key":"1334_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.thromres.2021.12.011","volume":"210","author":"E Sonne-Holm","year":"2022","unstructured":"Sonne-Holm, E. et al. Pulmonary embolism: age specific temporal trends in incidence and mortality in Denmark 1999\u20132018. Thromb. Res. 210, 12\u201319 (2022).","journal-title":"Thromb. Res."},{"key":"1334_CR67","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.thromres.2019.02.009","volume":"176","author":"AM M\u00fcnster","year":"2019","unstructured":"M\u00fcnster, A. M. et al. A changing landscape: temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006\u20132015. Thromb. Res. 176, 46\u201353 (2019).","journal-title":"Thromb. Res."},{"key":"1334_CR68","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.thromres.2020.07.011","volume":"195","author":"W Ghanima","year":"2020","unstructured":"Ghanima, W. et al. Incidence and prevalence of venous thromboembolism in Norway 2010\u20132017. Thromb. Res. 195, 165\u2013168 (2020).","journal-title":"Thromb. Res."},{"key":"1334_CR69","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jtha.2024.12.040","volume":"23","author":"S Wolf","year":"2025","unstructured":"Wolf, S. et al. Acute pulmonary embolism with and without hemodynamic instability (2003\u20132022): a Swiss nationwide epidemiologic study. J. Thromb. Haemost. 23, 1340\u20131351 (2025).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2018.10.001","volume":"277","author":"A Kempny","year":"2019","unstructured":"Kempny, A. et al. Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015. Int. J. Cardiol. 277, 229\u2013234 (2019).","journal-title":"Int. J. Cardiol."},{"key":"1334_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101433","volume":"58","author":"X Zhong","year":"2025","unstructured":"Zhong, X. et al. Temporal trends in hospital-recorded pulmonary embolism in England before, during and after the COVID-19 pandemic (2008\u20132024): a population-based observational study. Lancet Reg. Health Eur. 58, 101433 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"1334_CR72","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.3390\/jcm9103221","volume":"9","author":"J de Miguel-Diez","year":"2020","unstructured":"de Miguel-Diez, J. et al. Changing trends in hospital admissions for pulmonary embolism in Spain from 2001 to 2018. J. Clin. Med. 9, 3221 (2020).","journal-title":"J. Clin. Med."},{"key":"1334_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/ehjqcco\/qcac020","volume":"9","author":"L Vicent","year":"2023","unstructured":"Vicent, L. et al. Sex differences in temporal trends in main and secondary pulmonary embolism diagnosis and case fatality rates: 2003-2019. Eur. Heart J. Qual. Care Clin. Outcomes 9, 184\u2013193 (2023).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"1334_CR74","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11239-022-02698-2","volume":"54","author":"M Sane","year":"2022","unstructured":"Sane, M. Utilization of D-dimer assay, CT angiography, and the incidence of pulmonary embolism in the hospital district of Helsinki and Uusimaa (2011\u20132017). J. Thromb. Thrombolysis 54, 579\u2013582 (2022).","journal-title":"J. Thromb. Thrombolysis"},{"key":"1334_CR75","first-page":"281","volume":"37","author":"G Cerini","year":"2025","unstructured":"Cerini, G. et al. Pulmonary embolism: incidence and outcomes in a twelve-year historical series, in Tuscany, Italy (2010\u20132021). Ann. Ig. 37, 281\u2013291 (2025).","journal-title":"Ann. Ig."},{"key":"1334_CR76","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1160\/th15-02-0172","volume":"115","author":"F Dentali","year":"2016","unstructured":"Dentali, F. et al. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb. Haemost. 115, 399\u2013405 (2016).","journal-title":"Thromb. Haemost."},{"key":"1334_CR77","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1093\/eurheartj\/ehaf211","volume":"46","author":"Q Chen","year":"2025","unstructured":"Chen, Q. et al. Incidence, risk factors, and mortality of pulmonary embolism in the Netherlands (2015\u201322): sex differences and shifts during the coronavirus disease 2019 pandemic. Eur. Heart J. 46, 2809\u20132821 (2025).","journal-title":"Eur. Heart J."},{"key":"1334_CR78","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/eurheartj\/ehz236","volume":"41","author":"K Keller","year":"2020","unstructured":"Keller, K. et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur. Heart J. 41, 522\u2013529 (2020).","journal-title":"Eur. Heart J."},{"key":"1334_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2023.11.002","volume":"31","author":"R Cal\u00e9","year":"2025","unstructured":"Cal\u00e9, R. et al. In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 2018. Pulmonology 31, 2416830 (2025).","journal-title":"Pulmonology"},{"key":"1334_CR80","doi-asserted-by":"publisher","first-page":"432","DOI":"10.20344\/amp.6367","volume":"29","author":"M Gouveia","year":"2016","unstructured":"Gouveia, M., Pinheiro, L., Costa, J. & Borges, M. [Pulmonary embolism in Portugal: epidemiology and in-hospital mortality]. Acta Med. Port. 29, 432\u2013440 (2016).","journal-title":"Acta Med. Port."},{"key":"1334_CR81","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1055\/s-0041-1725932","volume":"121","author":"S Hoskin","year":"2021","unstructured":"Hoskin, S., Brieger, D., Chow, V., Kritharides, L. & Ng, A. C. C. Trends in acute pulmonary embolism admission rates and mortality outcomes in Australia, 2002\u20132003 to 2017\u20132018: a retrospective cohort study. Thromb. Haemost. 121, 1237\u20131245 (2021).","journal-title":"Thromb. Haemost."},{"key":"1334_CR82","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e130","volume":"37","author":"HG Hwang","year":"2022","unstructured":"Hwang, H. G. et al. Incidence of venous thromboembolism: the 3rd Korean Nationwide study. J. Korean Med. Sci. 37, e130 (2022).","journal-title":"J. Korean Med. Sci."},{"key":"1334_CR83","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.chest.2018.10.040","volume":"155","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China. Chest 155, 342\u2013353 (2019).","journal-title":"Chest"},{"key":"1334_CR84","doi-asserted-by":"publisher","first-page":"e0191897","DOI":"10.1371\/journal.pone.0191897","volume":"13","author":"J Hong","year":"2018","unstructured":"Hong, J. et al. Incidence of venous thromboembolism in Korea from 2009 to 2013. PLoS One 13, e0191897 (2018).","journal-title":"PLoS One"},{"key":"1334_CR85","volume":"54","author":"K Zhen","year":"2025","unstructured":"Zhen, K. et al. Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study. Lancet Reg. Health West. Pac. 54, 101258 (2025).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1334_CR86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-9560-11-16","volume":"11","author":"FJ V\u00e1zquez","year":"2013","unstructured":"V\u00e1zquez, F. J., Posadas-Mart\u00ednez, M. L., Vicens, J., Gonz\u00e1lez Bernaldo de Quir\u00f3s, F. & Giunta, D. H. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb. J. 11, 16 (2013).","journal-title":"Thromb. J."},{"key":"1334_CR87","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S2213-2600(20)30417-3","volume":"9","author":"S Barco","year":"2021","unstructured":"Barco, S. et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir. Med. 9, 33\u201342 (2021).","journal-title":"Lancet Respir. Med."},{"key":"1334_CR88","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jacc.2026.01.071","volume":"87","author":"M Ahmed","year":"2026","unstructured":"Ahmed, M. et al. Pulmonary embolism attributed hospitalization and mortality in the United States, 2016 2022. J. Am. Coll. Cardiol. 87, 1535\u20131538 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR89","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1055\/a-2031-3859","volume":"123","author":"C Becattini","year":"2023","unstructured":"Becattini, C. et al. Contemporary management and clinical course of acute pulmonary embolism: the cope study. Thromb. Haemost. 123, 613\u2013626 (2023).","journal-title":"Thromb. Haemost."},{"key":"1334_CR90","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s11136-019-02175-z","volume":"28","author":"LH Chuang","year":"2019","unstructured":"Chuang, L. H. et al. Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries. Qual. Life Res. 28, 2111\u20132124 (2019).","journal-title":"Qual. Life Res."},{"key":"1334_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12520","volume":"5","author":"S Barco","year":"2021","unstructured":"Barco, S. et al. Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: vital registration data from 123 countries. Res. Pract. Thromb. Haemost. 5, e12520 (2021).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1334_CR92","doi-asserted-by":"publisher","first-page":"2002963","DOI":"10.1183\/13993003.02963-2020","volume":"58","author":"Z Zhai","year":"2021","unstructured":"Zhai, Z. et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES). Eur. Respir. J. 58, 2002963 (2021).","journal-title":"Eur. Respir. J."},{"key":"1334_CR93","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.thromres.2023.12.016","volume":"234","author":"R Chatani","year":"2024","unstructured":"Chatani, R. et al. Cancer-associated venous thromboembolism in the direct oral anticoagulants era: insight from the COMMAND VTE registry-2. Thromb. Res. 234, 86\u201393 (2024).","journal-title":"Thromb. Res."},{"key":"1334_CR94","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jacc.2015.10.060","volume":"67","author":"D Jimenez","year":"2016","unstructured":"Jimenez, D. et al. Trends in the management and outcomes of acute pulmonary embolism: analysis from the riete registry. J. Am. Coll. Cardiol. 67, 162\u2013170 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR95","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.thromres.2022.11.016","volume":"222","author":"AGG Turpie","year":"2023","unstructured":"Turpie, A. G. G. et al. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb. Res. 222, 31\u201339 (2023).","journal-title":"Thromb. Res."},{"key":"1334_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103389","volume":"86","author":"H Hagiya","year":"2025","unstructured":"Hagiya, H. et al. Global trends in mortality related to pulmonary embolism: an epidemiological analysis of data from the World Health Organization mortality database from 2001 to 2023. EClinicalMedicine 86, 103389 (2025).","journal-title":"EClinicalMedicine"},{"key":"1334_CR97","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S2213-2600(19)30354-6","volume":"8","author":"S Barco","year":"2020","unstructured":"Barco, S. et al. Trends in mortality related to pulmonary embolism in the European Region, 2000\u201315: analysis of vital registration data from the WHO Mortality Database. Lancet Respir. Med. 8, 277\u2013287 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1334_CR98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.thromres.2023.11.008","volume":"232","author":"AC Chen","year":"2023","unstructured":"Chen, A. C. et al. Comparing US and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry. Thromb. Res. 232, 123\u2013132 (2023).","journal-title":"Thromb. Res."},{"key":"1334_CR99","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4236\/wjcd.2018.82012","volume":"8","author":"F Kamdem","year":"2018","unstructured":"Kamdem, F. et al. Epidemiology, clinical presentations and in-hospital mortality of venous thromboembolism at the Douala General Hospital: a cross-sectional study in Cameroon, Sub-Saharan Africa. World J. Cardiovascular Dis. 8, 123\u2013132 (2018).","journal-title":"World J. Cardiovascular Dis."},{"key":"1334_CR100","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.jtha.2023.03.026","volume":"21","author":"FB Rinde","year":"2023","unstructured":"Rinde, F. B. et al. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry. J. Thromb. Haemost. 21, 1861\u20131868 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR101","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.2147\/IJGM.S359893","volume":"15","author":"FAS AlEidan","year":"2022","unstructured":"AlEidan, F. A. S. et al. Incidence and predictors of recurrence and mortality following first venous thromboembolism among the Saudi population: single-center cohort study. Int. J. Gen. Med. 15, 7559\u20137568 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"1334_CR102","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.thromres.2019.10.029","volume":"184","author":"Y Yamashita","year":"2019","unstructured":"Yamashita, Y. et al. Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry. Thromb. Res. 184, 50\u201357 (2019).","journal-title":"Thromb. Res."},{"key":"1334_CR103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.amjcard.2022.03.060","volume":"176","author":"R Sedhom","year":"2022","unstructured":"Sedhom, R. et al. Contemporary national trends and outcomes of pulmonary embolism in the United States. Am. J. Cardiol. 176, 132\u2013138 (2022).","journal-title":"Am. J. Cardiol."},{"key":"1334_CR104","doi-asserted-by":"publisher","first-page":"e0260036","DOI":"10.1371\/journal.pone.0260036","volume":"16","author":"AJ Weekes","year":"2021","unstructured":"Weekes, A. J. et al. Development and validation of a prognostic tool: pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE). PLoS One 16, e0260036 (2021).","journal-title":"PLoS One"},{"key":"1334_CR105","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.chest.2016.02.638","volume":"150","author":"SB Smith","year":"2016","unstructured":"Smith, S. B. et al. Analysis of national trends in admissions for pulmonary embolism. Chest 150, 35\u201345 (2016).","journal-title":"Chest"},{"key":"1334_CR106","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.amjmed.2025.08.035","volume":"139","author":"F Lonnberg","year":"2026","unstructured":"Lonnberg, F. & Siddiqui, A. J. Risk of cardiovascular events in patients diagnosed with venous thromboembolism. Am. J. Med. 139, 181\u2013188.e3 (2026).","journal-title":"Am. J. Med."},{"key":"1334_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.109168","volume":"243","author":"KC Christodoulou","year":"2024","unstructured":"Christodoulou, K. C. et al. Evolving patterns of intracranial hemorrhage in advanced therapies in patients with acute pulmonary embolism. Thromb. Res. 243, 109168 (2024).","journal-title":"Thromb. Res."},{"key":"1334_CR108","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1055\/s-0040-1720977","volume":"121","author":"D Spirk","year":"2021","unstructured":"Spirk, D. et al. Clinical outcomes of incidental venous thromboembolism in cancer and noncancer patients: the Swiss Venous Thromboembolism Registry (SWIVTER). Thromb. Haemost. 121, 641\u2013649 (2021).","journal-title":"Thromb. Haemost."},{"key":"1334_CR109","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S2213-2600(24)00412-0","volume":"13","author":"S Wolf","year":"2025","unstructured":"Wolf, S. et al. Acute pulmonary embolism in children and adolescents in the USA (2016 and 2019): a nationwide retrospective cohort study. Lancet Respir. Med. 13, 393\u2013402 (2025).","journal-title":"Lancet Respir. Med."},{"key":"1334_CR110","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/blood.2019000918","volume":"135","author":"M Abbattista","year":"2020","unstructured":"Abbattista, M., Capecchi, M. & Martinelli, I. Treatment of unusual thrombotic manifestations. Blood 135, 326\u2013334 (2020).","journal-title":"Blood"},{"key":"1334_CR111","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","volume":"398","author":"F Khan","year":"2021","unstructured":"Khan, F., Tritschler, T., Kahn, S. R. & Rodger, M. A. Venous thromboembolism. Lancet 398, 64\u201377 (2021).","journal-title":"Lancet"},{"key":"1334_CR112","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/EDE.0b013e318296c2b6","volume":"24","author":"H Kelly","year":"2013","unstructured":"Kelly, H. & Cowling, B. J. Case fatality: rate, ratio, or risk? Epidemiology 24, 622\u2013623 (2013).","journal-title":"Epidemiology"},{"key":"1334_CR113","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1473-3099(20)30424-2","volume":"21","author":"MS Han","year":"2021","unstructured":"Han, M. S., Byun, J. H., Cho, Y. & Rim, J. H. RT\u2013PCR for SARS-CoV-2: quantitative versus qualitative. Lancet Infect. Dis. 21, 165 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1334_CR114","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/jth.12301","volume":"11","author":"W Ageno","year":"2013","unstructured":"Ageno, W., Squizzato, A., Wells, P. S., Buller, H. R. & Johnson, G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J. Thromb. Haemost. 11, 1597\u20131602 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR115","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1183\/09031936.00049312","volume":"41","author":"IM Lang","year":"2013","unstructured":"Lang, I. M., Pesavento, R., Bonderman, D. & Yuan, J. X. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur. Respir. J. 41, 462\u2013468 (2013).","journal-title":"Eur. Respir. J."},{"key":"1334_CR116","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.114.009309","volume":"130","author":"IM Lang","year":"2014","unstructured":"Lang, I. M. & Madani, M. Update on chronic thromboembolic pulmonary hypertension. Circulation 130, 508\u2013518 (2014).","journal-title":"Circulation"},{"key":"1334_CR117","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman, S. & Kearon, C. Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J. Thromb. Haemost. 3, 692\u2013694 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR118","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz, S., Ahmad, D., Spyropoulos, A. C. & Schulman, S. Subcommittee on Control of A. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J. Thromb. Haemost. 13, 2119\u20132126 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR119","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1161\/CIRCULATIONAHA.119.041346","volume":"140","author":"BA Bergmark","year":"2019","unstructured":"Bergmark, B. A. et al. Comparison of events across bleeding scales in the ENGAGE AF-TIMI 48 trial. Circulation 140, 1792\u20131801 (2019).","journal-title":"Circulation"},{"key":"1334_CR120","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1161\/CIRCULATIONAHA.111.032433","volume":"123","author":"KA Hicks","year":"2011","unstructured":"Hicks, K. A., Stockbridge, N. L., Targum, S. L. & Temple, R. J. Bleeding academic research consortium consensus report: the Food and Drug Administration perspective. Circulation 123, 2664\u20132665 (2011).","journal-title":"Circulation"},{"key":"1334_CR121","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/jth.14769","volume":"18","author":"T Tritschler","year":"2020","unstructured":"Tritschler, T. et al. Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: communication from the SSC of the ISTH. J. Thromb. Haemost. 18, 1495\u20131500 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR122","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.117.033427","volume":"137","author":"ZH Tseng","year":"2018","unstructured":"Tseng, Z. H. et al. Prospective countywide surveillance and autopsy characterization of sudden cardiac death: post scd study. Circulation 137, 2689\u20132700 (2018).","journal-title":"Circulation"},{"key":"1334_CR123","unstructured":"Wells G. A. et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale (2000)."},{"key":"1334_CR124","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa2415879","volume":"393","author":"C Magnussen","year":"2025","unstructured":"Magnussen, C. et al. Global effect of cardiovascular risk factors on lifetime estimates. N. Engl. J. Med. 393, 125\u2013138 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1334_CR125","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/jth.12698","volume":"12","author":"ISTH Steering Committee for World Thrombosis Day.","year":"2014","unstructured":"ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J. Thromb. Haemost. 12, 1580\u20131590 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR126","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/eurjpc\/zwaf307","volume":"32","author":"L Valerio","year":"2025","unstructured":"Valerio, L. et al. Burden and long-term impact of pulmonary embolism on health-related quality of life: a matched cohort study. Eur. J. Prev. Cardiol. 32, 1506\u20131514 (2025).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"1334_CR127","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/00033197211070889","volume":"73","author":"L Spiezia","year":"2022","unstructured":"Spiezia, L. et al. Risk factors for post-thrombotic syndrome in patients with a first proximal deep venous thrombosis treated with direct oral anticoagulants. Angiology 73, 649\u2013654 (2022).","journal-title":"Angiology"},{"key":"1334_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1250480","volume":"10","author":"T Yu","year":"2023","unstructured":"Yu, T., Song, J., Yu, L. & Deng, W. A systematic evaluation and meta-analysis of early prediction of post-thrombotic syndrome. Front. Cardiovasc. Med. 10, 1250480 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"1334_CR129","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/eurheartj\/ehab816","volume":"43","author":"FA Klok","year":"2022","unstructured":"Klok, F. A. et al. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. Eur. Heart J. 43, 183\u2013189 (2022).","journal-title":"Eur. Heart J."},{"key":"1334_CR130","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1378\/chest.09-2482","volume":"138","author":"FA Klok","year":"2010","unstructured":"Klok, F. A. et al. Quality of life in long-term survivors of acute pulmonary embolism. Chest 138, 1432\u20131440 (2010).","journal-title":"Chest"},{"key":"1334_CR131","doi-asserted-by":"publisher","first-page":"e013086","DOI":"10.1136\/bmjopen-2016-013086","volume":"6","author":"M Tavoly","year":"2016","unstructured":"Tavoly, M. et al. Health-related quality of life after pulmonary embolism: a cross-sectional study. BMJ open. 6, e013086 (2016).","journal-title":"BMJ open."},{"key":"1334_CR132","doi-asserted-by":"publisher","first-page":"e024805","DOI":"10.1136\/bmjopen-2018-024805","volume":"9","author":"R Hunter","year":"2019","unstructured":"Hunter, R., Noble, S., Lewis, S. & Bennett, P. Long-term psychosocial impact of venous thromboembolism: a qualitative study in the community. BMJ open. 9, e024805 (2019).","journal-title":"BMJ open."},{"key":"1334_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105978","volume":"167","author":"I Kirchberger","year":"2020","unstructured":"Kirchberger, I. et al. The lived experience with pulmonary embolism: a qualitative study using focus groups. Respir. Med. 167, 105978 (2020).","journal-title":"Respir. Med."},{"key":"1334_CR134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.thromres.2021.07.004","volume":"205","author":"JS Danielsbacka","year":"2021","unstructured":"Danielsbacka, J. S., Rostberg, L., Olsen, M. F. & Mannerkorpi, K. \u2018Whole life changed\u2019 \u2014 experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study. Thromb. Res. 205, 56\u201362 (2021).","journal-title":"Thromb. Res."},{"key":"1334_CR135","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1055\/s-0042-1749659","volume":"49","author":"D Luijten","year":"2023","unstructured":"Luijten, D. et al. Post-pulmonary embolism syndrome and functional outcomes after acute pulmonary embolism. Semin. Thromb. Hemost. 49, 848\u2013860 (2023).","journal-title":"Semin. Thromb. Hemost."},{"key":"1334_CR136","doi-asserted-by":"publisher","first-page":"2300846","DOI":"10.1183\/13993003.00846-2023","volume":"63","author":"C Durrington","year":"2024","unstructured":"Durrington, C. et al. Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry. Eur. Respir. J. 63, 2300846 (2024).","journal-title":"Eur. Respir. J."},{"key":"1334_CR137","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035997","volume":"13","author":"N Ikeda","year":"2024","unstructured":"Ikeda, N. et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism in the era of direct oral anticoagulants: from the COMMAND VTE Registry-2. J. Am. Heart Assoc. 13, e035997 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"1334_CR138","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1182\/bloodadvances.2022007263","volume":"7","author":"E Ferrazzini","year":"2023","unstructured":"Ferrazzini, E. et al. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism. Blood Adv. 7, 205\u2013213 (2023).","journal-title":"Blood Adv."},{"key":"1334_CR139","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno, W. et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141, e44S\u2013e88S (2012).","journal-title":"Chest"},{"key":"1334_CR140","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1161\/CIR.0000000000001306","volume":"151","author":"EA Takahashi","year":"2025","unstructured":"Takahashi, E. A. et al. Disparities in current pulmonary embolism management and outcomes: a scientific statement from the American Heart Association. Circulation 151, e944\u2013e955 (2025).","journal-title":"Circulation"},{"key":"1334_CR141","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1016\/j.jtha.2025.07.026","volume":"23","author":"D Omar","year":"2025","unstructured":"Omar, D. et al. Racial disparities in the incidence and risk factors of major bleeding during extended anticoagulant therapy for venous thromboembolism. J. Thromb. Haemost. 23, 3590\u20133600 (2025).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR142","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim, H. K. et al. The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb. Haemost. 121, 422\u2013432 (2021).","journal-title":"Thromb. Haemost."},{"key":"1334_CR143","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","volume":"3","author":"L Gervaso","year":"2021","unstructured":"Gervaso, L., Dave, H. & Khorana, A. A. Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 3, 173\u2013190 (2021).","journal-title":"JACC CardioOncol."},{"key":"1334_CR144","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder, F. I. et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137, 1959\u20131969 (2021).","journal-title":"Blood"},{"key":"1334_CR145","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","volume":"6","author":"A Mahajan","year":"2022","unstructured":"Mahajan, A., Brunson, A., Adesina, O., Keegan, T. H. M. & Wun, T. The incidence of cancer-associated thrombosis is increasing over time. Blood Adv. 6, 307\u2013320 (2022).","journal-title":"Blood Adv."},{"key":"1334_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102101","volume":"4","author":"J Trujillo-Santos","year":"2025","unstructured":"Trujillo-Santos, J., Ay, C., Bikdeli, B. et al. Variation in venous thromboembolism outcomes based on primary cancer site: a RIETE Registry analysis. JACC Adv. 4, 102101 (2025).","journal-title":"JACC Adv."},{"key":"1334_CR147","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom, J. W. et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J. Thromb. Haemost. 4, 529\u2013535 (2006).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR148","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1358863X18754692","volume":"23","author":"G Alotaibi","year":"2018","unstructured":"Alotaibi, G., Wu, C., Senthilselvan, A. & McMurtry, M. S. Short- and long-term mortality after pulmonary embolism in patients with and without cancer. Vasc. Med. 23, 261\u2013266 (2018).","journal-title":"Vasc. Med."},{"key":"1334_CR149","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jaccao.2023.09.003","volume":"5","author":"L Bertoletti","year":"2023","unstructured":"Bertoletti, L. et al. Cancer-associated thrombosis: trends in clinical features, treatment, and outcomes from 2001 to 2020. JACC CardioOncol 5, 758\u2013772 (2023).","journal-title":"JACC CardioOncol"},{"key":"1334_CR150","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/jth.15729","volume":"20","author":"X Jordan Bruno","year":"2022","unstructured":"Jordan Bruno, X. et al. Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study. J. Thromb. Haemost. 20, 1645\u20131652 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR151","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ajh.20983","volume":"82","author":"FA Anderson Jr.","year":"2007","unstructured":"Anderson, F. A. Jr., Zayaruzny, M., Heit, J. A., Fidan, D. & Cohen, A. T. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am. J. Hematol. 82, 777\u2013782 (2007).","journal-title":"Am. J. Hematol."},{"key":"1334_CR152","doi-asserted-by":"publisher","first-page":"e914","DOI":"10.1161\/CIR.0000000000000769","volume":"141","author":"PK Henke","year":"2020","unstructured":"Henke, P. K. et al. Call to action to prevent venous thromboembolism in hospitalized patients: a policy statement from the American Heart Association. Circulation 141, e914\u2013e931 (2020).","journal-title":"Circulation"},{"key":"1334_CR153","first-page":"809","volume":"22","author":"AK Jha","year":"2013","unstructured":"Jha, A. K. et al. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual. Saf. 22, 809\u2013815 (2013).","journal-title":"BMJ Qual. Saf."},{"key":"1334_CR154","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.thromres.2022.04.019","volume":"214","author":"B Bikdeli","year":"2022","unstructured":"Bikdeli, B. et al. Sex differences in presentation, risk factors, drug and interventional therapies, and outcomes of elderly patients with pulmonary embolism: rationale and design of the SERIOUS-PE study. Thromb. Res. 214, 122\u2013131 (2022).","journal-title":"Thromb. Res."},{"key":"1334_CR155","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","volume":"37","author":"CAL Arnesen","year":"2022","unstructured":"Arnesen, C. A. L., Veres, K., Horvath-Puho, E., Hansen, J. B., Sorensen, H. T. & Braekkan, S. K. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur. J. Epidemiol. 37, 195\u2013203 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"1334_CR156","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/humupd\/dmt028","volume":"19","author":"ESHRE Capri Workshop Group.","year":"2013","unstructured":"ESHRE Capri Workshop Group. Venous thromboembolism in women: a specific reproductive health risk. Hum. Reprod. Update 19, 471\u2013482 (2013).","journal-title":"Hum. Reprod. Update"},{"key":"1334_CR157","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1055\/s-0043-1764231","volume":"49","author":"B Bikdeli","year":"2023","unstructured":"Bikdeli, B. et al. Sex-related differences in patient characteristics, risk factors, and symptomatology in older adults with pulmonary embolism: findings from the SERIOUS-PE study. Semin. Thromb. Hemost. 49, 725\u2013735 (2023).","journal-title":"Semin. Thromb. Hemost."},{"key":"1334_CR158","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/1358863X241292023","volume":"30","author":"B Bikdeli","year":"2025","unstructured":"Bikdeli, B. et al. Sex differences in treatment strategies for pulmonary embolism in older adults: the SERIOUS-PE study of RIETE participants and US Medicare beneficiaries. Vasc. Med. 30, 58\u201366 (2025).","journal-title":"Vasc. Med."},{"key":"1334_CR159","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jth.14629","volume":"18","author":"S Barco","year":"2020","unstructured":"Barco, S. et al. Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry. J. Thromb. Haemost. 18, 151\u2013161 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR160","doi-asserted-by":"publisher","first-page":"e35150","DOI":"10.1097\/MD.0000000000035150","volume":"103","author":"Y Lai","year":"2024","unstructured":"Lai, Y. et al. Gender differences in the incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a meta-analysis. Medicine 103, e35150 (2024).","journal-title":"Medicine"},{"key":"1334_CR161","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024358","volume":"11","author":"PL Lutsey","year":"2022","unstructured":"Lutsey, P. L. et al. Incidence and risk factors of pulmonary hypertension after venous thromboembolism: an analysis of a large health care database. J. Am. Heart Assoc. 11, e024358 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"1334_CR162","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/GCO.0000000000000286","volume":"28","author":"JK Moulder","year":"2016","unstructured":"Moulder, J. K., Siedhoff, M. T., Till, S. R. & Moll, S. Management considerations for patients with uterine fibroids and concurrent venous thromboembolism. Curr. Opin. Obstet. Gynecol. 28, 329\u2013335 (2016).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"1334_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2024.104246","volume":"53","author":"P Mismetti","year":"2024","unstructured":"Mismetti, P., Bertoletti, L., Gouin, I., Emmerich, J. & Monreal, M. Elderly patients with venous thromboembolism: insights from the RIETE registry. Presse Med. 53, 104246 (2024).","journal-title":"Presse Med."},{"key":"1334_CR164","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","volume":"5","author":"IA Naess","year":"2007","unstructured":"Naess, I. A. et al. Incidence and mortality of venous thrombosis: a population-based study. J. Thromb. Haemost. 5, 692\u2013699 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR165","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.arbres.2023.12.016","volume":"60","author":"AG Ortega","year":"2024","unstructured":"Ortega, A. G. et al. Age-related differences in the presentation, management, and clinical outcomes of 100,000 patients with venous thromboembolism in the RIETE registry. Arch. Bronconeumol. 60, 143\u2013152 (2024).","journal-title":"Arch. Bronconeumol."},{"key":"1334_CR166","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/ajh.26996","volume":"98","author":"K Giorgio","year":"2023","unstructured":"Giorgio, K. et al. Venous thromboembolism mortality and trends in older US adults, 2011\u20132019. Am. J. Hematol. 98, 1364\u20131373 (2023).","journal-title":"Am. J. Hematol."},{"key":"1334_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100147","volume":"7","author":"IT Farmakis","year":"2023","unstructured":"Farmakis, I. T. et al. Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample. Res. Pract. Thromb. Haemost. 7, 100147 (2023).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1334_CR168","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1160\/TH15-04-0330","volume":"114","author":"L Tang","year":"2015","unstructured":"Tang, L. & Hu, Y. Ethnic diversity in the genetics of venous thromboembolism. Thromb. Haemost. 114, 901\u2013909 (2015).","journal-title":"Thromb. Haemost."},{"key":"1334_CR169","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1001\/archinte.164.16.1804","volume":"164","author":"PD Stein","year":"2004","unstructured":"Stein, P. D., Kayali, F., Olson, R. E. & Milford, C. E. Pulmonary thromboembolism in American Indians and Alaskan Natives. Arch. Intern. Med. 164, 1804\u20131806 (2004).","journal-title":"Arch. Intern. Med."},{"key":"1334_CR170","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1160\/TH17-02-0134","volume":"117","author":"LH Lee","year":"2017","unstructured":"Lee, L. H., Gallus, A., Jindal, R., Wang, C. & Wu, C. C. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb. Haemost. 117, 2243\u20132260 (2017).","journal-title":"Thromb. Haemost."},{"key":"1334_CR171","doi-asserted-by":"publisher","first-page":"e066644","DOI":"10.1136\/bmjopen-2022-066644","volume":"13","author":"H Tabassum","year":"2023","unstructured":"Tabassum, H. et al. Development of prospective hospital-based venous thromboembolism registry across India: a study protocol. BMJ open. 13, e066644 (2023).","journal-title":"BMJ open."},{"key":"1334_CR172","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jacc.2022.08.721","volume":"80","author":"IT Farmakis","year":"2022","unstructured":"Farmakis, I. T. et al. Annual mortality related to pulmonary embolism in the US before and during the COVID-19 pandemic. J. Am. Coll. Cardiol. 80, 1579\u20131581 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR173","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","volume":"22","author":"EM Conway","year":"2022","unstructured":"Conway, E. M. et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 22, 639\u2013649 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1334_CR174","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.044011","volume":"14","author":"B Bikdeli","year":"2025","unstructured":"Bikdeli, B. et al. Adjudicated cardiovascular events in patients with COVID-19: association with vaccination status and changes over time. J. Am. Heart Assoc. 14, e044011 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"1334_CR175","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","volume":"76","author":"G Piazza","year":"2020","unstructured":"Piazza, G. et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J. Am. Coll. Cardiol. 76, 2060\u20132072 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR176","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","volume":"159","author":"D Jimenez","year":"2021","unstructured":"Jimenez, D. et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest 159, 1182\u20131196 (2021).","journal-title":"Chest"},{"key":"1334_CR177","doi-asserted-by":"publisher","first-page":"e232338","DOI":"10.1001\/jamanetworkopen.2023.2338","volume":"6","author":"MC Fang","year":"2023","unstructured":"Fang, M. C. et al. Assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19. JAMA Netw. Open. 6, e232338 (2023).","journal-title":"JAMA Netw. Open."},{"key":"1334_CR178","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2020.09.006","volume":"82","author":"L Roncon","year":"2020","unstructured":"Roncon, L. et al. Incidence of acute pulmonary embolism in COVID-19 patients: systematic review and meta-analysis. Eur. J. Intern. Med. 82, 29\u201337 (2020).","journal-title":"Eur. J. Intern. Med."},{"key":"1334_CR179","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/rth2.12391","volume":"4","author":"S Nopp","year":"2020","unstructured":"Nopp, S. et al. Pulmonary embolism during the COVID-19 pandemic: decline in diagnostic procedures and incidence at a university hospital. Res. Pract. Thromb. Haemost. 4, 835\u2013841 (2020).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1334_CR180","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jacc.2026.01.067","volume":"87","author":"Y Yamashita","year":"2026","unstructured":"Yamashita, Y., Sawano, M., You, S., White, H. D. & Zhai, Z. An Asia Pacific perspective on the 2026 ACC\/AHA Guideline for Acute Pulmonary Embolism. J. Am. Coll. Cardiol. 87, 1610\u20131613 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR181","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"GBD 2021 Adult BMI Collaborators.","year":"2025","unstructured":"GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 405, 813\u2013838 (2025).","journal-title":"Lancet"},{"key":"1334_CR182","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1334_CR183","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41514-024-00148-2","volume":"10","author":"CH Jones","year":"2024","unstructured":"Jones, C. H. & Dolsten, M. Healthcare on the brink: navigating the challenges of an aging society in the United States. NPJ Aging 10, 22 (2024).","journal-title":"NPJ Aging"},{"key":"1334_CR184","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli, B. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75, 2950\u20132973 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR185","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","volume":"123","author":"RH White","year":"2009","unstructured":"White, R. H. & Keenan, C. R. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb. Res. 123, S11\u2013S17 (2009).","journal-title":"Thromb. Res."},{"key":"1334_CR186","doi-asserted-by":"publisher","first-page":"e0005209","DOI":"10.1371\/journal.pgph.0005209","volume":"5","author":"C Barrabi","year":"2025","unstructured":"Barrabi, C. & Foster, C. Elevated cardiovascular risk factors and chronic disease mortality in the Caribbean: a cross-sectional study. PLOS Glob. Public. Health 5, e0005209 (2025).","journal-title":"PLOS Glob. Public. Health"},{"key":"1334_CR187","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0140-6736(21)01257-5","volume":"398","author":"J Soar","year":"2021","unstructured":"Soar, J. et al. Cardiopulmonary resuscitation in special circumstances. Lancet 398, 1257\u20131268 (2021).","journal-title":"Lancet"},{"key":"1334_CR188","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjcard.2022.01.051","volume":"171","author":"M Zuin","year":"2022","unstructured":"Zuin, M. et al. Prevalence of acute pulmonary embolism at autopsy in patients with COVID-19. Am. J. Cardiol. 171, 159\u2013164 (2022).","journal-title":"Am. J. Cardiol."},{"key":"1334_CR189","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jtha.2024.10.013","volume":"23","author":"B Bikdeli","year":"2025","unstructured":"Bikdeli, B. et al. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism. J. Thromb. Haemost. 23, 556\u2013564 (2025).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR190","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.thromres.2019.11.018","volume":"185","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli, B., Carrier, M. & Bates, S. M. Subsegmental pulmonary embolism: may not be a killer but indicates significant risk. Thromb. Res. 185, 180\u2013182 (2020).","journal-title":"Thromb. Res."},{"key":"1334_CR191","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jacc.2026.01.071","volume":"87","author":"M Ahmed","year":"2026","unstructured":"Ahmed, M. et al. Pulmonary embolism-attributed hospitalization and mortality in the United States, 2016\u20132022. J. Am. Coll. Cardiol. 87, 1535\u20131538 (2026).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1334_CR192","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators.","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132 (2024).","journal-title":"Lancet"},{"key":"1334_CR193","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1055\/a-2039-3222","volume":"123","author":"B Bikdeli","year":"2023","unstructured":"Bikdeli, B. et al. Developing validated tools to identify pulmonary embolism in electronic databases: rationale and design of the PE-EHR+ study. Thromb. Haemost. 123, 649\u2013662 (2023).","journal-title":"Thromb. Haemost."},{"key":"1334_CR194","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1055\/a-2554-0043","volume":"51","author":"S Rashedi","year":"2025","unstructured":"Rashedi, S. et al. Use of present-on-admission indicators to improve accuracy of pulmonary embolism identification from electronic health record data. Semin. Thromb. Hemost. 51, 829\u2013833 (2025).","journal-title":"Semin. Thromb. Hemost."},{"key":"1334_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100754","volume":"5","author":"IT Farmakis","year":"2023","unstructured":"Farmakis, I. T. et al. Maternal mortality related to pulmonary embolism in the United States, 2003\u20132020. Am. J. Obstet. Gynecol. MFM 5, 100754 (2023).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"1334_CR196","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jacc.2025.12.088","volume":"87","author":"SM Bates","year":"2026","unstructured":"Bates, S. M., Bikdeli, B. & Hunt, B. J. Sex, pregnancy, and reproductive health in acute pulmonary embolism. J. Am. Coll. Cardiology 87, 1550\u20131553 (2026).","journal-title":"J. Am. Coll. Cardiology"},{"key":"1334_CR197","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/rth2.12482","volume":"5","author":"W Ageno","year":"2021","unstructured":"Ageno, W. et al. Provoked versus unprovoked venous thromboembolism: findings from GARFIELD-VTE. Res. Pract. Thromb. Haemost. 5, 326\u2013341 (2021).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1334_CR198","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1160\/TH17-07-0511","volume":"118","author":"B Bikdeli","year":"2018","unstructured":"Bikdeli, B. et al. For the RIETE investigators. Rationale, design and methodology of the computerized registry of patients with venous thromboembolism (RIETE). Thromb. Haemost. 118, 214\u2013224 (2018).","journal-title":"Thromb. Haemost."},{"key":"1334_CR199","doi-asserted-by":"publisher","unstructured":"J\u00f8rgensen, C. T. et al. The venous thrombosis registry in \u00d8stfold Hospital (TROLL registry) \u2014 design and cohort description. Res. Pract. Thromb. Haemost. 6, e12770 https:\/\/doi.org\/10.1002\/rth2.12770 (2022).","DOI":"10.1002\/rth2.12770"},{"key":"1334_CR200","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12959-015-0071-z","volume":"13","author":"G Agnelli","year":"2015","unstructured":"Agnelli, G. et al. for the PREFER in VTE investigators. The management of acute venous thromboembolism in clinical practice \u2014 study rationale and protocol of the European PREFER in VTE Registry. Thromb. J. 13, 41 (2015).","journal-title":"Thromb. J."},{"key":"1334_CR201","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1160\/TH16-04-0335","volume":"116","author":"JI Weitz","year":"2016","unstructured":"Weitz, J. I. et al. Global anticoagulant registry in the field \u2014 venous thromboembolism (GARFIELD-VTE). Rationale and design. Thromb. Haemost. 116, 1172\u20131179 (2016).","journal-title":"Thromb. Haemost."},{"key":"1334_CR202","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00392-023-02323-z","volume":"113","author":"C Becattini","year":"2024","unstructured":"Becattini, C. et al. for the COPE investigators. Acute pulmonary embolism and cancer: findings from the COPE study. Clin. Res. Cardiol. 113, 288\u2013300 (2024).","journal-title":"Clin. Res. Cardiol."},{"key":"1334_CR203","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","volume":"170","author":"D Jimenez","year":"2010","unstructured":"Jimenez, D. et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch. Intern. Med. 170, 1383\u20131389 (2010).","journal-title":"Arch. Intern. Med."},{"key":"1334_CR204","volume":"17","author":"RS Zhang","year":"2024","unstructured":"Zhang, R. S. et al. Composite pulmonary embolism shock score and risk of adverse outcomes in patients with pulmonary embolism. Circ. Cardiovasc. Interv. 17, e014088 (2024).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1334_CR205","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1538-7836.2011.04388.x","volume":"9","author":"W Zondag","year":"2011","unstructured":"Zondag, W. et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J. Thromb. Haemost. 9, 1500\u20131507 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"1334_CR206","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"SV Konstantinides","year":"2020","unstructured":"Konstantinides, S. V. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart J. 41, 543\u2013603 (2020).","journal-title":"Eur. Heart J."},{"key":"1334_CR207","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.jacc.2025.11.005","volume":"87","author":"MA Creager","year":"2026","unstructured":"Creager, M. A. et al. 2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN guideline for the evaluation and management of acute pulmonary embolism in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 87, 1626\u20131710 https:\/\/doi.org\/10.1016\/j.jacc.2025.11.005 (2026).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01334-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:01:21Z","timestamp":1790510481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":207,"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01334-3","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"3 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.B. reports that he is a member of the Medical Advisory Board for the VascuLearn Network and serves on the Data Safety and Monitoring Board of the NAIL-IT trial funded by the National Heart, Lung, and Blood Institute and Translational Sciences. B.B. is a collaborating consultant with the International Consulting Associates and the FDA in a study to generate knowledge about utilization, predictors, retrieval and safety of inferior vena cava filters. B.B. was supported by a Career Development Award from the American Heart Association and Vascular InterVentional Advances (VIVA) Physicians (#938814). B.B. receives compensation as an Associate Editor for the\n                      New England Journal of Medicine\n                      Journal Watch Cardiology, as an Associate Editor for\n                      Thrombosis Research\n                      and as an Executive Associate Editor for the\n                      Journal of the American College of Cardiology\n                      , and is a Section Editor for\n                      Thrombosis and Haemostasis\n                      (no compensation). M.S. has received partial research funding through Yale University from Novartis, Pfizer and PolyBio, has received lecture honoraria from Abbott and Boehringer Ingelheim, and receives compensation for his role as Executive Associate Editor for the\n                      Journal of the American College of Cardiology\n                      . P.A. has received research support paid to his institution from BIOCAD, Novo Nordisk and Sanofi. D.J. has received research support paid to his institution from the European Union Horizon Europe research and innovation programme, La Caixa Foundation and Instituto de Salud Carlos III, and is a Section Editor for\n                      Thrombosis and Haemostasis\n                      (no compensation). M.M. has received unrestricted educational grants from several pharmaceutical companies (Rovi and Sanofi) and the Universidad Cat\u00f3lica San Antonio de Murcia (Spain) to support the RIETE registry; these funds were paid to his institution. L.B. reports grants, personal fees and non-financial support from Bayer and Merck Sharp and Dohme, personal fees and non-financial support from Bristol Myers Squibb\u2013Pfizer, L\u00e9o-Pharma and Viatris and non-financial support from Johnson and Johnson and Opalia-Recordati. E.R. reports grants and consulting fees from Ach\u00e9 Pharma, Althaia Pharma, Bayer, EMS Pharmaceuticals and Novartis, and research grants from Althaia Pharma, Bayer, Bi\u00f2s Pharmaceutical, the Brazilian Ministry of Science and Technology, Novartis and Stin Pharma. F.A.K. has received research funding from Actelion, Angiodynamics, AstraZeneca, Bayer, Bristol Myers Squibb, BSCI, the Dutch Heart Foundation, the Dutch Thrombosis Foundation, Farm-X, the Horizon Europe Programme, Leo Pharma, Merck Sharp & Dohme and the Netherlands Organisation for Health Research and Development, all paid to his institution. F.K. reports employment for Bristol Myers Squibb. H.G. has received consulting fees from Bayer Australia, Bristol Myers Squibb and Medtronic Australia. A.T.C. receives consulting fees and\/or research funding from Abbott, AbbVie, ACI Clinical, AstraZeneca, Bayer, Boston Scientific, Bristol Myers Squibb, Daiichi-Sankyo, EmstoPA Ltd, Janssen, Johnson & Johnson, Medscape, Medtronic, McKinsey, Novartis, Pfizer, Sanofi, VarmX and Viatris. G.Y.H.L. is a consultant and speaker for Anthos, Bristol Myers Squibb\u2013Pfizer, Boehringer Ingelheim and Huawei (no fees are received personally). M.C. is a Councillor of the International Society on Thrombosis and Haemostasis. G.P. has received research support paid to his institution from Alexion, Amgen, Bayer, Boston Scientific Corporation, Bristol Myers Squibb\u2013Pfizer, Esperion and Janssen, and consulting fees from Amgen, Boston Clinical Research Institute, Boston Scientific Corporation, Bristol Myers Squibb\u2013Pfizer, Janssen, North American Science Associates (NAMSA), Penumbra, Regeneron and Thrombolex. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}